Initial Safety Trial Results Find Increased Risk of Serious Heart-Related Problems and Cancer with Xeljanz, Xeljanz XR (tofacitinib)

xloma.fota13 shared this article with you from Inoreader Initial Safety Trial Results Find Increased Risk of Serious Heart-Related Problems and Cancer with Xeljanz, Xeljanz XR (tofacitinib) Via Drugs.com - FDA MedWatch Alerts Audience: Consumer, Patient, Health Professional, Pharmacy February 4, 2021 -- The U.S. Food and Drug Administration (FDA) is alerting the public that preliminary results from a safety clinical trial show an increased risk of serious heart-related... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.